User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Direct-acting antivirals for paediatric HCV: we got there

  1. Wirth Stefan, Current treatment options and response rates in children with chronic hepatitis C, 10.3748/wjg.v18.i2.99
  2. Pawlotsky Jean-Michel, Feld Jordan J., Zeuzem Stefan, Hoofnagle Jay H., From non-A, non-B hepatitis to hepatitis C virus cure, 10.1016/j.jhep.2015.02.006
  3. Druyts Eric, Thorlund Kristian, Wu Ping, Kanters Steve, Yaya Sanni, Cooper Curtis L., Mills Edward J., Efficacy and Safety of Pegylated Interferon Alfa-2a or Alfa-2b Plus Ribavirin for the Treatment of Chronic Hepatitis C in Children and Adolescents: A Systematic Review and Meta-analysis, 10.1093/cid/cis1031
  4. EASL Recommendations on Treatment of Hepatitis C 2016, 10.1016/j.jhep.2016.09.001
  5. Bortolotti Flavia, Verucchi Gabriella, Cammà Calogero, Cabibbo Giuseppe, Zancan Lucia, Indolfi Giuseppe, Giacchino Raffaella, Marcellini Matilde, Marazzi Maria Grazia, Barbera Cristiana, Maggiore Giuseppe, Vajro Pietro, Bartolacci Samuela, Balli Fiorella, Maccabruni Anna, Guido Maria, Long-Term Course of Chronic Hepatitis C in Children: From Viral Clearance to End-Stage Liver Disease, 10.1053/j.gastro.2008.02.082
Bibliographic reference Sokal, Etienne. Direct-acting antivirals for paediatric HCV: we got there. In: Nature Reviews. Gastroenterology & Hepatology, Vol. 14, no. 8, p. 452-453 (2017)
Permanent URL http://hdl.handle.net/2078.1/186851